-
Mashup Score: 0Performing Automatic Identification and Staging of Urothelial Carcinoma in Bladder Cancer Patients Using a Hybrid Deep-Machine Learning Approach - 1 year(s) ago
Accurate clinical staging of bladder cancer aids in optimizing the process of clinical decision-making, thereby tailoring the effective treatment and management of patients. While several radiomics approaches have been developed to facilitate the process of clinical diagnosis and staging of bladder cancer using grayscale computed tomography (CT) scans, the performances of these models have been…
Source: MDPICategories: Latest Headlines, UrologyTweet
-
Mashup Score: 3Role of Cell-Free Urine and Plasma DNA Mutation Analysis in Predicting Neoadjuvant Chemotherapy Response and Outcomes in Patients With MIBC - 1 year(s) ago
Read it now on PracticeUpdate.com
Source: PracticeUpdateCategories: Hem/Oncs, Latest HeadlinesTweet-
Urine tumor (ut)-DNA (supernatant [supe] & pellet) & circulating tumor (ct)-DNA in muscle-invasive #bladdercancer receiving Neoadjuvant #Chemo (NAC)-#ctDNA before NAC, ctDNA/utDNA (supe/pellet) after NAC=lower response rate; ctDNA/utDNA-supe DNA dynamics https://t.co/53dDOEUNqa… https://t.co/QJzhXy7FiK
-
-
Mashup Score: 1Search of: Recruiting Studies | Interventional Studies | celebration | Phase Early Phase 1, 1 - List Results - ClinicalTrials.gov - 1 year(s) ago
Modify Search Start Over 7 Studies found for: Recruiting Studies | Interventional Studies | celebration | Phase Early Phase 1, 1 Applied Filters: Recruiting…
Source: clinicaltrials.govCategories: Hem/Oncs, Latest HeadlinesTweet-
We offer cutting edge #clinicaltrials of novel treatments for #cancer in our growing Phase I program @AdventHealthCFL Celebration, #Florida-#immunotherapy #targeted therapy, antibody drug conjugates (ADC) & more-central Florida deserves the best-https://t.co/JnDaf8MFBQ https://t.co/lZbpZEFurD
-
-
Mashup Score: 0
AdventHealth, AdventHealth Cancer Institute, Journal Club
Source: web.cvent.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Pleased to speak at the #prostatecancer Update 2023 arranged by @AdventHealthCFL-we discuss cutting edge therapy & emerging advances-a hybrid & dinner event 6-830 pm EST on Thursday 20 April at the Alfond inn, Winter Park, #Florida-event offers #CME & MOC https://t.co/tiSkriST1q
-
-
Mashup Score: 2Efficacy of High- and Low-Dose Preoperative Ipilimumab Plus Nivolumab in Patients With Stage III Urothelial Cancer - 1 year(s) ago
Written by Rafee Talukder MD
Source: PracticeUpdateCategories: Hem/Oncs, Latest HeadlinesTweet-
Preoperative high-dose Ipilimumab+Nivolumab appeared active (pCR 43-46%) in muscle-invasive #urothelialcarcinoma-will it improve outcomes as first-line therapy in cisplatin-ineligible advanced disease (CHECKMATE901)-comment @rafee_talukder https://t.co/cyEi2CRfeC @practiceupdate
-
-
Mashup Score: 0Emerging monoclonal antibody therapies in the treatment of metastatic urothelial carcinoma - 1 year(s) ago
The treatment landscape for advanced-stage, unresectable or metastatic urothelial carcinoma (mUC) has shifted dramatically over a short period of time, with new therapeutic agents available for cli…
Source: Taylor & FrancisCategories: Hem/Oncs, Latest HeadlinesTweet-
Monoclonal antibodies (non-ICI) for metastatic #urothelialcarcinoma #bladdercancer-we review previously investigated targets (VEGF,VEGFR2,Her2,Her3, FGFR3,KIR2) & those undergoing investigation (IL6,CD38,CD40,BTLA,RNP)-need #precisiononcology @rohitjainMD https://t.co/DddSqIWS94
-
-
Mashup Score: 3ASCO GU 2023: Adjuvant Nivolumab Benefit Persists in High-Risk Muscle-Invasive Urothelial Carcinoma - 1 year(s) ago
Read it now on PracticeUpdate.com
Source: PracticeUpdateCategories: Hem/Oncs, Latest HeadlinesTweet-
#GU23:CHECKMATE274 update-Adjuvant Nivolumab extends DFS (v placebo) in High-Risk Muscle-Invasive #urothelialcarcinoma in overall (HR 0.71, median 22 v 10.9 mo) & PD-L1+ tumors (HR 0.52, median 8.4 v 52.6 mo)-no new toxicities @MattGalsky https://t.co/zV6AcVjf8m @practiceupdate
-
-
Mashup Score: 0ASCO GU 2023: Atezolizumab Does Not Improve Overall Survival in Advanced or Metastatic Urothelial Carcinoma - 1 year(s) ago
Read it now on PracticeUpdate.com
Source: PracticeUpdateCategories: Hem/Oncs, Latest HeadlinesTweet-
#GU23: IMvigor130 phase III trial-Atezo+Gem-platinum did Not Improve Survival in Advanced #urothelialcarcinoma-but signal of benefit with the cisplatin+gem backbone-Bodes well for #CHECKMATE901 sub-study (cis-gem+/-Nivo) @MattGalsky? https://t.co/4htufzPKpH @practiceupdate
-
-
Mashup Score: 0Unlocking cancer biomarkers with AI - 1 year(s) ago
Revitalizing the cancer therapeutics industry – 90% of clinical trials fail, with the average trial costing $793M. Despite its $100K/year price, immunotherapy is only partially effective in 17% of patients.
Source: key.bioCategories: Hem/Oncs, Latest HeadlinesTweet-
Neural network analysis of germline+tumor molecular alterations shows large impact of host to predict 5-yr survival with high accuracy post-#radicalcystectomy for muscle-invasive #bladdercancer @LayneSadler https://t.co/meEm1f6TxI https://t.co/6VnqZ9fTCz @onclive
-
-
Mashup Score: 4Unlocking cancer biomarkers with AI - 1 year(s) ago
Revitalizing the cancer therapeutics industry – 90% of clinical trials fail, with the average trial costing $793M. Despite its $100K/year price, immunotherapy is only partially effective in 17% of patients.
Source: key.bioCategories: Hem/Oncs, Latest HeadlinesTweet-
#GU23-Highlights with @CParkMD-also our novel deep learning model including host & tumor molecular platforms to predict 5-yr survival of muscle-invasive #bladdercancer-large impact of germline #genetics! @LayneSadler https://t.co/meEm1f6TxI https://t.co/Wemu6liRPT @vumedi
-
Staging of #bladdercancer to identify muscle-invasion using a Hybrid #DeepLearning #MachineLearning Approach applied to #radiomics on CT scans-honored to coauthor in work led by #DrSuryadiptoSarkar-coauthors @TeresaWuMD @Parminder1699 @IrbazRiaz https://t.co/wA6ihD77k3… https://t.co/LK81TE2VJ6 https://t.co/Qq6Vb0UnQm